MLSS MILESTONE SCIENTIFIC INC.

NYSE milestonescientific.com


$ 0.45 $ -0.03 (-5.38 %)    

Thursday, 16-Oct-2025 15:52:36 EDT
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 0.4452
$ 0.50
$ 0.40 x 5,262
$ 0.48 x 100
$ 0.44 - $ 0.50
$ 0.38 - $ 1.39
201,391
na
34.97M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 04-15-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-13-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-31-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 04-06-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 milestone-scientific-q2-eps-002-misses-001-estimate-sales-2323m-miss-2600m-estimate

Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of ...

 milestone-scientific-q1-eps-002-misses-001-estimate-sales-223m-miss-243m-estimate

Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of ...

 milestone-scientific-announces-commercial-implementation-of-compuflo-epidural-system-at-pain-doctors-medical-using-dynamic-pressure-sensing-technology-for-enhanced-patient-safety-and-procedural-efficiency

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and ...

 milestone-scientific-secures-federal-supply-schedule-approval-on-contract-for-compuflo-epidural-system

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and ...

 benchmark-reiterates-speculative-buy-on-milestone-scientific-maintains-125-price-target

Benchmark analyst Bruce Jackson reiterates Milestone Scientific (AMEX:MLSS) with a Speculative Buy and maintains $1.25 price...

 milestone-scientific-q3-eps-002-misses-001-estimate-sales-251m-miss-261m-estimate

Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of ...

 milestone-scientific-announces-arjan-haverhals-will-retire-from-his-role-as-ceo-of-the-company-on-december-31-2024-neal-goldman-chairman-of-the-board-has-been-appointed-as-interim-ceo

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and ...

 benchmark-initiates-coverage-on-milestone-scientific-with-speculative-buy-rating-announces-price-target-of-125

Benchmark analyst Bruce Jackson initiates coverage on Milestone Scientific (AMEX:MLSS) with a Speculative Buy rating and ann...

 milestone-scientific-announces-commercial-rollout-of-compuflo-epidural-system-at-iheal-pain-center-following-medicare-price-assignment

Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION